Why October is key: A handful of coronavirus vaccine candidates near the end of late stage clinical trials this month. Further, two frontrunners — Pfizer and Moderna — are set to release their late-stage and Phase 2 results as well. While experts say the vaccine will be available by April 2021, firms have been far more ambitious with their estimates. In fact, Moderna is eyeing the emergency-use authorisation route to launch their vaccine by year-end. India, too, is in the race with two vaccines in phase II trials and the one by Oxford in phase III. October, therefore, could prove to be the crucial month as far as development of an effective vaccine against the pandemic goes and a clearer picture of the progress made so far is expected to emerge by the time November arrives.
Read more here